Daniel Mark James
Atossa Therapeutics, Inc. · Chief Financial Officer
Daniel Mark James is listed in public filings as officer: Chief Financial Officer. This Daniel Mark James insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Atossa Therapeutics, Inc. (ATOS). Investors use Daniel Mark James's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --63k shares | Grant / ExerciseMar 26, 2026 | Disclosure amount unavailable63k shares | -- | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $595k578k shares | Grant / ExerciseOct 14, 2025 | $595.3K578k shares | $1.03 | -- |